Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
ViaNautis
ViaNautis is a pioneering biotechnology company focused on developing genetic nanomedicines using its proprietary polyNaut® technology. This innovative platform utilizes advanced polymer materials…
ViaNautis
ViaNautis is a pioneering biotechnology company focused on developing genetic nanomedicines using its proprietary polyNaut® technology. This innovative platform utilizes advanced polymer materials…
TL;DR
What: Biotech developing polyNaut® polymer-based genetic nanomedicines for targeted delivery (e.g., crossing the blood–brain barrier).
Founded: 2018 (UCL spin-out, formerly SomaServe)
HQ: Cambridge, United Kingdom
Stage / Size: Early-stage private company; reported headcount range ~11–50 (public listings show 49 employees)
Notable investors: 4BIO Capital, BGF Ventures, UCB Ventures, Eli Lilly, Cystic Fibrosis Foundation
Company Overview
Problem Domain
Targeted delivery of genetic medicines and crossing biological barriers (e.g., blood–brain barrier).
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
25000000
Series A announced to advance polyNaut® genetic nanomedicines; company press materials cite a $25 million Series A.
Investor Signal
“Consortium includes strategic pharma and philanthropic participants (Eli Lilly, Cystic Fibrosis Foundation) alongside venture investors, indicating both strategic and disease-focused backing.”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,600+
New This Week